SeekingAlpha · Jan 18, 2026
NHS: Dividend Isn't Supported By Earnings
Neuberger High Yield Strategies' 14.9% yield is attractive, but net investment income consistently falls short of distributions. Read more on NHS CEF here.
NH
NASDAQ · NHS
Neuberger Berman High Yield Strategies Fund Inc.
Financial Services · Asset Management
$5.66
Down-$0.04 (-0.69%)
Updated Sep 16, 2026, 12:09 PM
SID Score
3.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 223.83M
- P/E ratio
- 11.87
- Dividend yield
- 20.89%
- 52-week range
- $5.75 – $7.57
- Volume
- 283.13K
- Avg. volume
- 189.3K
Price performance
NHS price history
1M range · 20 trading sessions · Daily adjusted prices
NHS closed at $5.66 after 20 trading sessions, down 5.82% for the selected period.
- Last close
- $5.66
- Period change
- -5.82%
- Period low
- $5.66
- Period high
- $6.01
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $5.68 | $5.68 | $5.6201 | $5.66 | 283.13K |
| Sep 14, 2026 | $5.85 | $5.85 | $5.75 | $5.79 | 477.27K |
| Sep 11, 2026 | $5.91 | $5.91 | $5.85 | $5.85 | 114.91K |
| Sep 10, 2026 | $5.91 | $5.916 | $5.87 | $5.88 | 125.11K |
| Sep 9, 2026 | $5.93 | $5.93 | $5.90 | $5.91 | 172.97K |
| Sep 8, 2026 | $5.92 | $5.929 | $5.91 | $5.91 | 103.17K |
| Sep 4, 2026 | $5.91 | $5.95 | $5.91 | $5.93 | 88.31K |
| Sep 3, 2026 | $5.94 | $5.98 | $5.93 | $5.94 | 60.17K |
| Sep 2, 2026 | $5.94 | $5.986 | $5.93 | $5.95 | 81.74K |
| Sep 1, 2026 | $5.94 | $5.95 | $5.92 | $5.94 | 324.96K |
| Aug 31, 2026 | $5.98 | $5.99 | $5.94 | $5.95 | 118.76K |
| Aug 28, 2026 | $5.97 | $5.98 | $5.95 | $5.97 | 98.55K |
| Aug 27, 2026 | $5.95 | $5.98 | $5.94 | $5.95 | 99.31K |
| Aug 26, 2026 | $6.00 | $6.0062 | $5.95 | $5.95 | 157.5K |
| Aug 25, 2026 | $5.97 | $6.01 | $5.946 | $6.00 | 160.58K |
| Aug 24, 2026 | $5.93 | $5.97 | $5.93 | $5.96 | 177.06K |
| Aug 21, 2026 | $5.96 | $5.9663 | $5.91 | $5.95 | 175.68K |
| Aug 20, 2026 | $6.01 | $6.0104 | $5.93 | $5.96 | 247.24K |
| Aug 19, 2026 | $6.02 | $6.02 | $5.99 | $5.99 | 109.52K |
| Aug 18, 2026 | $5.99 | $6.0212 | $5.98 | $6.01 | 132.4K |
Latest NHS news
The latest Smart Investors Daily articles mentioning NHS.
Stock researchCompany · Overview
NHS research
Overview
Company profile and research snapshot.
Company profile
Neuberger Berman High Yield Strategies Fund Inc is a diversified, closed-end management investment company. The company invests in high yield debt securities market. The Fund uses leverage to pursue its investment objective. The Fund may invest in a variety of direct debt instruments, including bank loans, notes and other interests in amounts owed to financial institutions by borrowers, such as companies and governments. Corporate loans in which the Fund may invest will consist of direct obligations of borrowers. The Fund may invest in corporate loans at origination as a co-lender or may acquire loans in the secondary market by purchasing participations in, assignments of or novations of corporate loans.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
Yahoo · Dec 31, 2025
NEUBERGER HIGH YIELD STRATEGIES FUND ANNOUNCES MONTHLY DISTRIBUTION
Neuberger High Yield Strategies Fund Inc. (NYSE American: NHS) (the "Fund") has announced a distribution declaration of $0.0905 per share of common stock. The distribution announced today is payable on January 30, 2026, has a record date of January 15, 2026, and has an ex-date of January 15, 2026.
businesswire.com · Dec 10, 2025
Barking, Havering and Redbridge University Hospitals NHS Trust selects Wolters Kluwer's UpToDate Enterprise Edition to advance clinical decision-making and patient care
WALTHAM, Mass.--(BUSINESS WIRE)--Wolters Kluwer Health today announced that Barking, Havering and Redbridge University Hospitals NHS Trust (BHRUT), an acute care provider serving East London and Essex, has adopted UpToDate® Enterprise Edition. The market-leading clinical decision support (CDS) system will help healthcare administrators and clinicians deliver consistently high-quality care across the Trust which is recognized as a center of excellence in neuroscience, stroke care, and maternity.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
